Toxoplasma infection among pregnant women in Switzerland: A crosssectional evaluation of regional and age-specific lifetime average annual incidence

American Journal of Epidemiology

Volumn 142, Issue 7, 1995, Pages 659-666

  Zuber, Patrick L F ^a   Jacquier, Patrick ^b   Hohlfeld, Patrick ^c   Walker, Alexander M ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Epidemiologic methods; Incidence; Pregnancy; Seroepidemiologic methods; Statistics; Toxoplasmosis.

Indexed keywords

ADULT; ARTICLE; HUMAN; INCIDENCE; LIFESPAN; MAJOR CLINICAL STUDY; PREGNANCY; STATISTICAL ANALYSIS; SWITZERLAND; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CROSS-SECTIONAL STUDIES; EMIGRATION AND IMMIGRATION; FEMALE; HUMAN; INCIDENCE; LINEAR MODELS; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RESIDENCE CHARACTERISTICS; SUPPORT, NON-U.S. GOV'T; SWITZERLAND; TOXOPLASMOSIS;

EID: 0028941834     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a117482     Document Type: Article

References (20)

1. Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. Philadelphia, PA: WB Saunders, 1990:90-105.
2. Antenatal screening for toxoplasmosis in the UK. (Editorial) Lancet 1990;2’346-8.
3. Jeannel D, Costagliola D, Niel G, et al. What is known about the prevention of congenital toxoplasmosis? Lancet 1990, 336: 359-61.
4. Desmonts G. Preventing congenital toxoplasmosis. Lancet 1990;336:1017-18.
5. Ades AE, Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data. Epidemiol Infect 1992;108:367-75.
6. Direction générale de la santé Toxoplasmose. Bull Epidémiol Hebdomadaire 1990, 4:13-14.
7. Stürchler D, Berger R, Just M. Die konnatale Toxoplasmose m der Schweiz. Schweiz Med Wochenschr 1987;117:161-7.
8. Office Federal de la Statistique, Switzerland. Annuaire statis-tique de la Suisse 1992. Zurich: Verlag Neue Zurcher Zeitung, 1991.
9. Ades AE, Nokes DJ. Modelmg age-and time-specific incidence from seroprevalence' toxoplasmosis. Am J Epidemiol 1993;137:1022-34.
10. Mann J, Tarantola DJM, Netter TW, eds. AIDS in the world. A global report. Cambridge, MA: Harvard University Press, 1992.
11. Walker J, Nokes DJ, Jennings R. Longitudinal study of toxoplasma seroprevalence in South Yorkshire. Epidemiol Infect 1992;108:99-106.
12. Nokes DJ, Forsgren M, Gille E, et al. Modeling toxoplasma incidence from longitudinal seroprevalence in Stockholm, Sweden. Parasitology 1993; 107.33-40.
13. Rothman KJ, ed. Modem epidemiology Boston: Little, Brown & Co, 1986.
14. Maleewong W, Lulitanond V, Pipitgool V, et al. Prevalence of toxoplasma antibodies in blood donors and pregnant women in Khon Kaen Province. J Med Assoc Thai 1989;72:256-9.
15. Choi W-Y, Nam H-W, Youn J-H, et al. Toxoplasma antibody titers by indirect latex agglutination test in patients of Kangnam St. Mary’s hospital and Cheju medical center Korean J Parasit 1989;27:171-5.
16. Gilbert RE, Tookey PA, Cubitt WD, et al. Prevalence of toxoplasma IgG among pregnant women in west London according to country of birth and ethnic group. BMJ 1993; 306.185.
17. Dubey JP, Beattie CP, eds. Toxoplasmosis of animals and man. Boca Raton, FL: CRC Press Inc, 1988.
18. Rawlins SC, Prabhakar P. Toxoplasmosis in young Jamaicans. J Trop Pediatr 1989;35:234-6.
19. Barbier D, Ancelle T, Martin-Bouyer G. Seroepidemiological survey of toxoplasmosis in La Guadeloupe, French West Indies. Am J Trap Med Hyg 1983;32:935-42.
20. van Druten H, van Knapen F, Reintjes A. Epidemiologic implications of limited-duration seropositivity after toxoplasma infection. Am J Epidemiol 1990;132:169-80.